Efficacy of CRISPR-Based Gene Editing in a Sickle Cell Disease Patient as Measured through the Eye

Sickle cell disease (SCD) exists on a phenotypic spectrum with variable genetic expressivity, making it difficult to assess an individual patient’s risk of complications at any particular point in time. Current and emerging SCD treatments, including CRISPR-based gene editing, result in a variable pr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Alexander Pinhas, Davis B. Zhou, Oscar Otero-Marquez, Maria V. Castanos Toral, Justin V. Migacz, Jeffrey Glassberg, Richard B. Rosen, Toco Y. P. Chui
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2022-01-01
coleção:	Case Reports in Hematology
Acesso em linha:	http://dx.doi.org/10.1155/2022/6079631
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!